BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 4818699)

  • 1. Dose-related hemodynamic and renal effects of dopamine in congestive heart failure.
    Beregovich J; Bianchi C; Rubler S; Lomnitz E; Cagin N; Levitt B
    Am Heart J; 1974 May; 87(5):550-7. PubMed ID: 4818699
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction.
    Dikshit K; Vyden JK; Forrester JS; Chatterjee K; Prakash R; Swan HJ
    N Engl J Med; 1973 May; 288(21):1087-90. PubMed ID: 4697939
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodynamic effects of diuresis by ethacrynic acid in normal subjects and in patients with congestive heart failure.
    Ramírez A; Abelmann WH
    Arch Intern Med; 1968 Apr; 121(4):320-7. PubMed ID: 5645703
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of refractory heart failure with infusion of nitroprusside.
    Guiha NH; Cohn JN; Mikulic E; Franciosa JA; Limas CJ
    N Engl J Med; 1974 Sep; 291(12):587-92. PubMed ID: 4855255
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined nitroprusside-dopamine therapy in severe chronic congestive heart failure. Dose-related hemodynamic advantages over single drug infusions.
    Stemple DR; Kleiman JH; Harrison DC
    Am J Cardiol; 1978 Aug; 42(2):267-75. PubMed ID: 685839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hemodynamic effects of ibopamine, a dopamine congener, in patients with congestive heart failure.
    Leier CV; Ren JH; Huss P; Unverferth DV
    Pharmacotherapy; 1986; 6(1):35-40. PubMed ID: 3952005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure.
    Ungar A; Fumagalli S; Marini M; Di Serio C; Tarantini F; Boncinelli L; Baldereschi G; Valoti P; La Cava G; Olianti C; Masotti G; Marchionni N
    Crit Care Med; 2004 May; 32(5):1125-9. PubMed ID: 15190961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Trimethoquinol by intravenous administration. I. Hemodynamic effects].
    Fumagalli G; Mazzola C; Cavallaro GF; Ghiringhelli G
    Clin Ter; 1976 Feb; 76(3):235-52. PubMed ID: 963963
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of dopamin in shock and heart failure (author's transl)].
    Aroński A; Kübler A; Sliwinski M; Paszkowska A
    Anaesthesist; 1978 Apr; 27(4):183-6. PubMed ID: 655365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and therapeutic effects of intravenous dopamine.
    Théroux P; Mizgala HF; Bourassa MG
    Can Med Assoc J; 1977 Mar; 116(6):645-8. PubMed ID: 608165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular pharmacology of dopexamine in low output congestive heart failure.
    Leier CV; Binkley PF; Carpenter J; Randolph PH; Unverferth DV
    Am J Cardiol; 1988 Jul; 62(1):94-9. PubMed ID: 2898209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of ethacrynic acid in anephric dogs.
    Ogilvie RI; Ruedy J
    J Pharmacol Exp Ther; 1971 Feb; 176(2):389-96. PubMed ID: 5568783
    [No Abstract]   [Full Text] [Related]  

  • 14. [Change of natriuresis during intravenous administration of benzohexonium].
    Kuz'min OB
    Farmakol Toksikol; 1970; 33(1):37-9. PubMed ID: 4393228
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
    Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
    Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure.
    Mehta J; Iacona M; Feldman RL; Pepine CJ; Conti CR
    Am J Cardiol; 1978 May; 41(5):925-30. PubMed ID: 645603
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemodynamic effects of intravenous frusemide in patients with myocardial infarction and left ventricular failure.
    Tattersfield AE; McNicol MW; Sillett RW
    Clin Sci Mol Med; 1974 Feb; 46(2):253-64. PubMed ID: 4817276
    [No Abstract]   [Full Text] [Related]  

  • 18. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
    Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
    Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of prolonged low dose dopamine in hospitalized patients with severe refractory heart failure.
    White DH; Crawford MH; O'Rourke RA
    Clin Cardiol; 1979 Apr; 2(2):135-9. PubMed ID: 262568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The atrial natriuretic factor in severe congestive heart failure. Plasma level, hemodynamic, hormonal and renal effects].
    Riegger AJ; Kromer EP; Kochsiek K
    Dtsch Med Wochenschr; 1985 Oct; 110(42):1607-10. PubMed ID: 2931268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.